Latest & greatest articles for mammography

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on mammography or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on mammography and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for mammography

1. Intraoperative Mammography for Breast Cancer Surgery: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines

Intraoperative Mammography for Breast Cancer Surgery: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines Intraoperative Mammography for Breast Cancer Surgery: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines | CADTH.ca Find the information you need Intraoperative Mammography for Breast Cancer Surgery: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines Intraoperative Mammography for Breast Cancer Surgery: A Review of Clinical (...) Effectiveness, Cost-Effectiveness, and Guidelines Last updated: April 22, 2019 Project Number: RC1102-000 Product Line: Research Type: Devices and Systems Report Type: Summary with Critical Appraisal Result type: Report Question What is the clinical effectiveness of intraoperative imaging with mammography for breast cancer surgery? What is the cost-effectiveness of intraoperative imaging with mammography for breast cancer surgery? What are the evidence-based guidelines regarding intraoperative imaging

2019 Canadian Agency for Drugs and Technologies in Health - Rapid Review

2. Choosing Wisely Canada recommendation - Don’t routinely do screening mammography for average risk women aged 40 – 49. Individual assessment of each woman’s preferences and risk should guide the discussion and decision regarding mammography screening in th

Choosing Wisely Canada recommendation - Don’t routinely do screening mammography for average risk women aged 40 – 49. Individual assessment of each woman’s preferences and risk should guide the discussion and decision regarding mammography screening in th Don’t do imaging for lower-back pain unless red flags are present. Red flags include, but are not limited to, severe or progressive neurological deficits or when serious underlying conditions such as osteomyelitis are suspected. Imaging (...) Vitamin D levels in patients with significant renal or metabolic disease. 1 2 3 Family Medicine Thirteen Things Physicians and Patients Should Question by College of Family Physicians of Canada Last updated: January 2018 4 5 6Don’t routinely do screening mammography for average risk women aged 40 – 49. Individual assessment of each woman’s preferences and risk should guide the discussion and decision regarding mammography screening in this age group. If, after this careful assessment and discussion

2019 CPG Infobase

3. Two-view digital breast tomosynthesis versus digital mammography in a population-based breast cancer screening programme (To-Be): a randomised, controlled trial

Two-view digital breast tomosynthesis versus digital mammography in a population-based breast cancer screening programme (To-Be): a randomised, controlled trial Digital breast tomosynthesis is an advancement of mammography, and has the potential to overcome limitations of standard digital mammography. This study aimed to compare first-generation digital breast tomo-synthesis including two-dimensional (2D) synthetic mammograms versus digital mammography in a population-based screening (...) programme.BreastScreen Norway offers all women aged 50-69 years two-view (craniocaudal and mediolateral oblique) mammographic screening every 2 years and does independent double reading with consensus. We asked all 32 976 women who attended the programme in Bergen in 2016-17, to participate in this randomised, controlled trial with a parallel group design. A study-specific software was developed to allocate women to either digital breast tomosynthesis or digital mammography using a 1:1 simple randomisation method

2019 EvidenceUpdates

4. Breast screening: IMS Giotto Class digital mammography system in 2D mode

Breast screening: IMS Giotto Class digital mammography system in 2D mode Breast screening: IMS Giotto Class digital mammography system in 2D mode - GOV.UK GOV.UK uses cookies to make the site simpler. Accept cookies You’ve accepted all cookies. You can at any time. Hide Search Guidance Breast screening: IMS Giotto Class digital mammography system in 2D mode Technical evaluation of the IMS Giotto Class digital mammography system in 2D mode, used in the NHS breast screening programme. Published 8 (...) July 2019 From: Documents Ref: PHE publications gateway number GW-524 If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email . Please tell us what format you need. It will help us if you say what assistive technology you use. Details The report is one of a series of technical reports evaluating commercially available mammography systems on behalf of the NHS breast screening programme. The report will help breast

2019 Public Health England

5. Siemens Revelation digital mammography system in 2D mode evaluation

Siemens Revelation digital mammography system in 2D mode evaluation NHS Breast Screening Programme Equipment Report Technical Evaluation of Siemens Revelation digital mammography system in 2D mode March 2019Technical evaluation Siemens Revelation digital mammography system in 2D mode 2 About Public Health England Public Health England exists to protect and improve the nation’s health and wellbeing, and reduce health inequalities. We do this through world-leading science, knowledge (...) evaluation of Siemens Revelation digital mammography system in 2D mode 3 Contents Executive summary 4 1. Introduction 5 1.1 Testing procedures and performance standards for digital mammography 5 1.2 Objectives 5 2. Methods 6 2.1 System tested 6 2.2 Output and HVL 7 2.3 Detector response 8 2.4 Dose measurement 8 2.5 Contrast-to-noise ratio 8 2.6 AEC performance for local dense areas 10 2.7 Noise analysis 11 2.8 Image quality measurements 12 2.9 Physical measurements of the detector performance 14 2.10

2019 Public Health England

6. Breast screening: Planmed Clarity digital mammography in 2D mode

Breast screening: Planmed Clarity digital mammography in 2D mode NHS Breast Screening Programme Equipment Report Technical Evaluation of Planmed Clarity digital mammography system in 2D mode March 2019Technical evaluation of Planmed Clarity digital mammography system in 2D mode 2 About Public Health England Public Health England exists to protect and improve the nation’s health and wellbeing, and reduce health inequalities. We do this through world-leading science, knowledge and intelligence (...) Development Goals Technical evaluation of Planmed Clarity digital mammography system in 2D mode 3 Contents About Public Health England 2 About PHE screening 2 Executive summary 4 1. Introduction 5 1.1 Testing procedures and performance standards for digital mammography 5 1.2 Objectives 5 2. Methods 6 2.1 System tested 6 2.2 Output and HVL 7 2.3 Detector response 7 2.4 Dose measurement 8 2.5 Contrast-to-noise ratio 8 2.6 AEC performance for local dense areas 10 2.7 Noise analysis 11 2.8 Image quality

2019 Public Health England

7. Breast screening: Hologic 3D digital mammography system in 2D mode

Breast screening: Hologic 3D digital mammography system in 2D mode NHS Breast Screening Programme Equipment Report Technical Evaluation of Hologic 3Dimensions digital mammography system in 2D mode March 2019Technical evaluation Hologic 3Dimensions digital mammography system in 2D mode 2 About Public Health England Public Health England exists to protect and improve the nation’s health and wellbeing, and reduce health inequalities. We do this through world-leading science, knowledge (...) 3Dimensions digital mammography system 3 Contents About Public Health England 2 About PHE screening 2 Executive summary 4 1. Introduction 5 1.1 Testing procedures and performance standards for digital mammography 5 1.2 Objectives 5 2. Methods 5 2.1 System tested 5 2.2 Output and half value layer 6 2.3 Detector response 7 2.4 Dose measurement 8 2.5 Contrast-to-noise ratio 8 2.6 AEC performance for local dense areas 10 2.7 Noise analysis 11 2.8 Image quality measurements 12 2.9 Physical measurements

2019 Public Health England

8. Self-compression Technique vs Standard Compression in Mammography: A Randomized Clinical Trial

Self-compression Technique vs Standard Compression in Mammography: A Randomized Clinical Trial Many women dread undergoing mammography, and some may not attend or reattend breast cancer screening because of the discomfort or pain induced by breast compression.To evaluate the noninferiority of the self-compression mammography technique for reducing breast thickness compared with standard compression.This prospective, parallel-group, noninferiority randomized clinical trial was conducted from May (...) does not appear to be inferior to standard compression mammography in achieving minimal breast thickness without increasing pain or compromising image quality; this technique may be an effective option for women who want to be involved in their breast examination.ClinicalTrials.gov identifier: NCT02866591.

2019 EvidenceUpdates

9. Diagnostic value of mammography associated to ultrasonography versus breast MRI abbreviated protocol for breast cancer screening in dense breasts at average risk: systematic review

Diagnostic value of mammography associated to ultrasonography versus breast MRI abbreviated protocol for breast cancer screening in dense breasts at average risk: systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email

2019 PROSPERO

10. A systematic review of cost effectiveness analysis (CEA) of mammography screening in low- and middle-income countries (LMICs)

A systematic review of cost effectiveness analysis (CEA) of mammography screening in low- and middle-income countries (LMICs) Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any

2019 PROSPERO

11. Effectiveness of tailored interventions on attendance at Pap test and mammography among ethnic minority women without previous screening history

Effectiveness of tailored interventions on attendance at Pap test and mammography among ethnic minority women without previous screening history Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO

12. Cost-effectiveness analysis of analog mammography compared to digital mammography in screening of women with breast cancer: a systematic review

Cost-effectiveness analysis of analog mammography compared to digital mammography in screening of women with breast cancer: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO

13. Impact of full field digital mammography (FFDM) diagnosis for patients with breast cancer (BC): a systematic review protocol of clinical studies

Impact of full field digital mammography (FFDM) diagnosis for patients with breast cancer (BC): a systematic review protocol of clinical studies Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO

14. Mammography

Mammography Top results for mammography - Trip Database or use your Google+ account Find evidence fast ALL of these words: Title only Anywhere in the document ANY of these words: Title only Anywhere in the document This EXACT phrase: Title only Anywhere in the document EXCLUDING words: Title only Anywhere in the document Timeframe: to: Combine searches by placing the search numbers in the top search box and pressing the search button. An example search might look like (#1 or #2) and (#3 or #4 (...) ) Loading history... Population: Intervention: Comparison: Outcome: Population: Intervention: Latest & greatest articles for mammography The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you

2018 Trip Latest and Greatest

15. Encapsulated Papillary Carcinoma in A Man with Gynecomastia: Ultrasonography, Mammography and Magnetic Resonance Imaging Features with Pathologic Correlation (PubMed)

Encapsulated Papillary Carcinoma in A Man with Gynecomastia: Ultrasonography, Mammography and Magnetic Resonance Imaging Features with Pathologic Correlation Male breast cancer is an uncommon disease that constitutes 1% of all breast cancers and encapsulated papillary carcinoma (EPC) is a rare subtype of malignant male diseases. Gynecomastia is the most common disease of the male breast. We report a 63-year-old male patient with EPC accompanied by gynecomastia that was diagnosed and treated (...) at our breast center. Mammography showed an oval-shaped dense mass with circumscribed margins on the ground of nodular gynecomastia. On ultrasonographic exam, we saw a well-circumscribed complex mass with a solid component which was vascular on Doppler ultrasonography. Magnetic resonance imaging revealed a complex cystic mass containing solid components. Dynamic images showed enhancement of the cystic mass wall and mural components. Tumor stage was evaluated as T2N0. The lesion's histologic

Full Text available with Trip Pro

2018 European journal of breast health

16. Motivators and barriers to mammography screening uptake by female health-care workers in primary health-care centres: a cross-sectional study. (PubMed)

Motivators and barriers to mammography screening uptake by female health-care workers in primary health-care centres: a cross-sectional study. Mammography screening is an effective tool for early detection and management of breast cancer. Female health-care workers' awareness of breast cancer screening is important because their beliefs and behaviours could influence other women. The aim of this study was to assess mammography screening uptake by female health-care workers at primary health (...) performed mammography for a suspected mass or other breast abnormalities were excluded. A self-administered questionnaire was used to collect data on demographic characteristics, knowledge about mammography screening, the extent and regularity of mammography screening, and motivators and barriers influencing their mammography screening uptake. The rate of mammography screening uptake was calculated. χ2 test and t tests were used to assess screening motivators and barriers. The study was approved

Full Text available with Trip Pro

2018 Lancet

17. Elimination of Cost Sharing for Screening Mammography in Medicare Advantage Plans. (PubMed)

Elimination of Cost Sharing for Screening Mammography in Medicare Advantage Plans. The Affordable Care Act (ACA) required most insurers and the Medicare program to eliminate cost sharing for screening mammography.We conducted a difference-in-differences study of biennial screening mammography among 15,085 women 65 to 74 years of age in 24 Medicare Advantage plans that eliminated cost sharing to provide full coverage for screening mammography, as compared with 52,035 women in 48 matched control (...) plans that had and maintained full coverage.In plans that eliminated cost sharing, adjusted rates of biennial screening mammography increased from 59.9% (95% confidence interval [CI], 54.9 to 65.0) in the 2-year period before cost-sharing elimination to 65.4% (95% CI, 61.8 to 69.0) in the 2-year period thereafter. In control plans, the rates of biennial mammography were 73.1% (95% CI, 69.2 to 77.0) and 72.8% (95% CI, 69.7 to 76.0) during the same periods, yielding a difference in differences of 5.7

Full Text available with Trip Pro

2018 NEJM

18. Technique and diagnostic performance of contrast-enhanced spectral mammography: a systematic review

Technique and diagnostic performance of contrast-enhanced spectral mammography: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web

2018 PROSPERO

19. Digital breast tomosynthesis (DBT) vs further diagnostic mammography in the assessment of recalled women of average risk of breast cancer due to malignancy suspicious lesions at mammography screening

Digital breast tomosynthesis (DBT) vs further diagnostic mammography in the assessment of recalled women of average risk of breast cancer due to malignancy suspicious lesions at mammography screening Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external

2018 PROSPERO

20. Accuracy of contrast enhanced mammography in neoadjuvant chemotherapy response monitoring

Accuracy of contrast enhanced mammography in neoadjuvant chemotherapy response monitoring Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Timing

2018 PROSPERO